Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS Trial.

MLA

Paradkar, Mandar S., et al. “Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS Trial.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 75, no. 9, Oct. 2022, pp. 1594–601. EBSCOhost, https://doi.org/10.1093/cid/ciac208.

APA

Paradkar, M. S., Devaleenal D, B., Mvalo, T., Arenivas, A., Thakur, K. T., Wolf, L., Nimkar, S., Inamdar, S., Giridharan, P., Selladurai, E., Kinikar, A., Valvi, C., Khwaja, S., Gadama, D., Balaji, S., Yadav Kattagoni, K., Venkatesan, M., Savic, R., Swaminathan, S., … Dooley, K. E. (2022). Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 75(9), 1594–1601. https://doi.org/10.1093/cid/ciac208

Chicago

Paradkar, Mandar S, Bella Devaleenal D, Tisungane Mvalo, Ana Arenivas, Kiran T Thakur, Lisa Wolf, Smita Nimkar, et al. 2022. “Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS Trial.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 75 (9): 1594–1601. doi:10.1093/cid/ciac208.